Fundraising FoxPhoenix Biotechnology
San Antonio, US · Texas corporation
Find your way into Phoenix Biotechnology
Sign up to see every warm intro you have to Phoenix Biotechnology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Phoenix Biotechnology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
CA
Crandell AddingtonNamed on SEC filing
AJ
Andrew J. ButlerNamed on SEC filing
JW
John W. CreamerNamed on SEC filing
MT
Macdonald T. HaskellNamed on SEC filing
LK
Lou KostNamed on SEC filing
RA
Robert A. NewmanNamed on SEC filing
JS
Jeffrey S. ThompsonNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$7.6M disclosed across 3 rounds · 2014–2020
▶$5MraisedAug 2020 · 1 investors · BiotechnologyRule 506(b)
▶$5MraisedAug 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Crandell AddingtonExecutive Officer, Director
- Jeffrey S. ThompsonDirector
- Andrew J. ButlerDirector
- Macdonald T. HaskellDirector
- Andrew WhitneyDirector
- Lou KostExecutive Officer, Director
- Robert A. NewmanExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $5M
- Minimum investment
- $5M
- First sale
- Aug 2020
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
▶$1.8MraisedOct 2019 · 25 investors · PharmaceuticalsRule 506(b)
▶$1.8MraisedOct 2019 · 25 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Crandell AddingtonExecutive Officer, Director
- Andrew J. ButlerDirector
- John W. CreamerDirector
- Macdonald T. HaskellDirector
- Lou KostExecutive Officer, Director
- Robert A. NewmanExecutive Officer, Director
- Jeffrey S. ThompsonDirector
- Amount sold
- $1.8M
- Minimum investment
- $9K
- First sale
- Jul 2018
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
▶$852KraisedJun 2014 · 23 investors · PharmaceuticalsRule 506(b)
▶$852KraisedJun 2014 · 23 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Macdonald T. HaskellDirector
- Andrew J. ButlerDirector
- Jeffrey S. ThompsonDirector
- Lou KostExecutive Officer, Director
- John W. CreamerDirector
- Crandell AddingtonExecutive Officer, Director
- Robert NewmanDirector
- Offering amount
- $2M
- Amount sold
- $852K
- Minimum investment
- $6K
- First sale
- Mar 2014
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Phoenix Biotechnology raised?
- Phoenix Biotechnology has disclosed $7.6M raised across 3 rounds.
- Where is Phoenix Biotechnology headquartered?
- Phoenix Biotechnology is headquartered in San Antonio, US.